XML 134 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Compensation Plans
12 Months Ended
Dec. 31, 2011
Stock Compensation Plans [Abstract]  
Stock Compensation Plans

Note 12 — Stock compensation plans

The Company has two stock-based compensation plans under which equity-based awards may be made. The Company's 2000 Stock Compensation Plan (the "2000 plan") provides for the granting of incentive and non-qualified stock options and restricted stock units to directors, officers and key employees. Under the 2000 plan, the Company is authorized to issue up to 4 million shares of common stock, but no more than 800,000 of those shares may be issued as restricted stock. Options granted under the 2000 plan have an exercise price equal to the average of the high and low sales prices of the Company's common stock on the date of the grant, rounded to the nearest $0.25. Generally, options granted under the 2000 plan are exercisable three to five years after the date of the grant and expire no more than ten years from the grant date. Outstanding restricted stock units generally vest in one to three years. In 2011, the Company granted incentive and non-qualified options to purchase 45,399 shares of common stock and granted restricted stock units representing 15,586 shares of common stock under the 2000 plan. The unrecognized compensation expense for these awards as of the grant date was $0.5 million, which will be recognized over the vesting period of the awards. As of December 31, 2011, 766,007 shares were available for future grants under the 2000 plan.

The Company's 2008 Stock Incentive Plan (the "2008 plan") provides for the granting of various types of equity-based awards to directors, officers and key employees. These awards include incentive and non-qualified stock options, stock appreciation rights, stock awards and other stock-based awards. Under the 2008 plan, the Company is authorized to issue up to 2.5 million shares of common stock, but grants of awards other than stock options and stock appreciation rights may not exceed 875,000 shares. Options granted under the 2008 plan have an exercise price equal to the closing price of the Company's common stock on the date of grant. In 2011, the Company granted incentive and non-qualified options to purchase 337,876 shares of common stock and granted restricted stock units representing 159,705 shares of common stock under the 2008 plan. The unrecognized compensation expense for these awards as of the grant date was $7.3 million, which will be recognized over the vesting period of the awards. As of December 31, 2011, 1,540,392 shares were available for future grants under the 2008 plan.

The fair value for options granted in 2011, 2010 and 2009 was estimated at the date of grant using a multiple point Black-Scholes option pricing model. The following weighted-average assumptions were used:

 

     2011     2010     2009  

Risk-free interest rate

     1.92     2.12     1.73

Expected life of option

     4.70 yrs.        4.66 yrs.        4.55 yrs.   

Expected dividend yield

     2.34     2.22     3.25

Expected volatility

     26.82     26.42     32.66

The fair value for non-vested shares granted in 2011, 2010 and 2009 was estimated at the date of grant based on the market rate on the grant date discounted for the risk free interest rate and the present value of expected dividends over the vesting period. The following weighted-average assumptions were used:

 

     2011     2010     2009  

Risk-free interest rate

     1.04     1.25     1.21

Expected dividend yield

     2.34     2.24     3.18

The Company applied a simplified method to establish the beginning balance of the additional paid-in capital pool ("APIC Pool") related to the tax effects of employee stock-based compensation and to determine the subsequent impact on the APIC Pool and consolidated statements of cash flows of the tax effects of employee stock-based compensation awards that are outstanding.

 

The following table summarizes the option activity during 2011:

 

     Shares
Subject to
Options
    Weighted
Average
Exercise
Price
     Weighted
Average
Remaining
Contractual
Life In
Years
     Aggregate Intrinsic
Value
 
                         (Dollars in thousands)  

Outstanding, beginning of the year

     2,274,627      $ 56.17         

Granted

     383,275        57.92         

Exercised

     (683,132     50.22         

Forfeited or expired

     (842,224     60.44         
  

 

 

         

Outstanding, end of the year

     1,132,546      $ 57.17         6.8       $ 5,613   
  

 

 

   

 

 

    

 

 

    

 

 

 

Exercisable, end of the year

     628,325      $ 56.31         5.2       $ 4,053   
  

 

 

   

 

 

    

 

 

    

 

 

 

The weighted average grant date fair value was $11.45, $12.29 and $9.70 for options granted during 2011, 2010 and 2009, respectively. The total intrinsic value of options exercised was $6.9 million, $2.3 million and $0.3 million during 2011, 2010 and 2009, respectively.

The Company recorded $1.1 million of expense related to the portion of the shares underlying options that vested during 2011, which is included in selling, general and administrative expenses.

The following table summarizes the non-vested restricted stock unit activity during 2011:

 

     Number of
Non-Vested
Shares
    Weighted
Average
Grant Date
Price
     Weighted
Average
Remaining
Contractual
Life In Years
     Aggregate Intrinsic
Value
 
                         (Dollars in thousands)  

Outstanding, beginning of the year

     386,543      $ 55.03         

Granted

     175,291        58.14         

Vested

     (90,508     57.14         

Forfeited

     (136,867     53.79         
  

 

 

         

Outstanding, end of the year

     334,459      $ 56.60         1.5       $ 20,499   
  

 

 

   

 

 

    

 

 

    

 

 

 

The weighted average grant-date fair value was $54.33, $57.09 and $42.76 for non-vested restricted stock units granted during 2011, 2010 and 2009, respectively.

The Company recorded $2.9 million of expense related to the portion of these shares that vested during 2011, which is included in selling, general and administrative expenses.